Page 3 - Bluechiip Enabled News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bluechiip Ltd (ASX:BCT) Lodgement of Open Briefing    Lodgement of Open BriefingMelbourne, May 27, 2021 AEST (ABN Newswire) - Bluechiip Ltd ( ASX:BCT) Lodgement of Open Briefing - Managing Director, Andrew McLellan: Bluechiip's results for Q3FY21; pipeline developments; direct to market strategy. In this Open Briefing(R), Andrew discusses sales activities, evaluations and market conditions. openbriefing.com Bluechiip's sales teams in the USA and Australia have resumed in-person product demonstrations, where possible, and recently installed evaluation systems into several customer sites...

Bluechiip Ltd (ASX:BCT) Quarterly Activity Report    Quarterly Activity Report Melbourne, April 28, 2021 AEST (ABN Newswire) - Bluechiip Limited ( ASX:BCT), a developer and leader in wireless tracking solution for the healthcare and life science, security, defence and manufacturing industries is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 March 2021. Corporate and Business updates for the Quarter - Progressive discussions and negotiations with potential OEMs including in the IVF market, Cell Therapy and target Biobanking space with...

Bluechiip Ltd (ASX:BCT) Receives $1.62 million R&D Tax Incentive Refund    Receives $1.62 million R&D Tax Incentive RefundMelbourne, Mar 15, 2021 AEST (ABN Newswire) - Bluechiip Limited ( ASX:BCT), a leader in the development of sample tracking technology for harsh environments, today announced that it has received $1.62M Research and Development Tax Incentive Refund from the Australian Tax Office for the financial year ended 30 June 2020. Andrew McLellan, Bluechiip Limited's Managing Director, welcomed the refund and said it would provide a significant cash injection for the Company, o...

Bluechiip Ltd (ASX:BCT) Quarterly Activity - Cashflow Report    Quarterly Activity - Cashflow ReportMelbourne, Jan 29, 2021 AEST (ABN Newswire) - Bluechiip Ltd ( ASX:BCT) sales and marketing teams both in Australia and the United States continue to make progressive negotiations with potential OEMs especially in the IVF and Cell Therapy markets despite current COVID-19 travel restrictions. The Company successfully delivered sales of $27K in developer kits through its distributor in China and Czech Republic and achieved sales of $31K for the quarter ended 31 December 2020. Ongoing improve...